Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications. - Test2 - elhamkhani - TriplyDB

Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.

Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.

http://www.wikidata.org/entity/Q33244196

about

Human malarial disease: a consequence of inflammatory cytokine release Discovery of Infection Associated Metabolic Markers in Human African Trypanosomiasis Extensive alterations of blood metabolites in pediatric cerebral malaria.Impaired systemic tetrahydrobiopterin bioavailability and increased oxidized biopterins in pediatric falciparum malaria: association with disease severity.Impaired systemic tetrahydrobiopterin bioavailability and increased dihydrobiopterin in adult falciparum malaria: association with disease severity, impaired microvascular function and increased endothelial activation.Metabolic Signature Profiling as a Diagnostic and Prognostic Tool in Pediatric Plasmodium falciparum Malaria Global host metabolic response to Plasmodium vivax infection: a 1H NMR based urinary metabonomic study.The role of previously unmeasured organic acids in the pathogenesis of severe malaria.Decreased Rate of Plasma Arginine Appearance in Murine Malaria May Explain Hypoargininemia in Children With Cerebral Malaria.Antiproliferative and antiplasmodial compounds from selected Streptomyces species.Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic Acid Simultaneous determination of multiple amino acids in plasma in critical illness by high performance liquid chromatography with ultraviolet and fluorescence detection.Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality?Urinary Metabolomics on the Biochemical Profiles in Diet-Induced Hyperlipidemia Rat Using Ultraperformance Liquid Chromatography Coupled with Quadrupole Time-of-Flight SYNAPT High-Definition Mass Spectrometry.Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.Serum Phenylalanine, Tyrosine, and their Ratio in Acute Ischemic Stroke: on the Trail of a Biomarker?Integrative metabolomics and transcriptomics signatures of clinical tolerance to Plasmodium vivax reveal activation of innate cell immunity and T cell signaling.Acidosis and acute kidney injury in severe malaria.

P2860

Q21034098-E03CF045-DA85-4019-B806-1E61FC5BDCED Q28550504-23C95D83-9FB1-4E8D-87BC-C6D521396D83 Q33584763-342627BC-3571-4B75-B0B4-0F7ED668363E Q35170667-99488E8E-ECC2-46F4-9F4A-F350139A7ABD Q35170674-B5801D12-EF83-4EBB-B863-4804B73A265A Q35757334-51E7168D-0B91-4787-BA48-AFB66F7983E0 Q35818517-86FDF8C7-B336-49DC-9A2E-B68720D8AB3D Q36032306-320794D9-E811-48D9-8C08-43B6FF5F49A9 Q36214599-8E4454A3-E9B9-4727-8D6F-26DBEC05143A Q36259504-7AE00855-DED6-47F9-B0F2-1E9560009DBB Q36442352-AC5E726C-92BA-4146-A10A-5AC46F3B16BB Q37374333-1C2C4A22-9C39-4511-89DB-190C900608DE Q37500605-CACD721F-212B-4949-BBB5-44F318D4716C Q37686855-A135E51B-9E5C-4346-977C-4B0F11C715B7 Q41195887-E839DBF4-8AF1-45A6-BB80-37F3597C52BE Q52148657-5B02AAC0-8A92-4F36-8ECC-CA1527691874 Q52308706-9D5906B8-8E05-49B2-9D04-A714BC146AB2 Q55236140-4E154A3E-6E1C-4734-843E-4993E7ED2F85

P2860

Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.

http://www.wikidata.org/entity/Q33244196

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Elevated plasma phenylalanine ...... of neurological complications.

@ast

Elevated plasma phenylalanine ...... of neurological complications.

@en

type

label

Elevated plasma phenylalanine ...... of neurological complications.

@ast

Elevated plasma phenylalanine ...... of neurological complications.

@en

prefLabel

Elevated plasma phenylalanine ...... of neurological complications.

@ast

Elevated plasma phenylalanine ...... of neurological complications.

@en

P1433

Q33244196-527C7262-1288-42EA-89A6-18FC7487BB09

P1476

Q33244196-36EC4458-0EF0-426E-97DA-A1645DC49086

P2093

Q33244196-1B81AAD5-2171-4F43-9288-0AE6009F80CD

Q33244196-22B1AC33-CBF6-4753-99F6-DDF7CABB758C

Q33244196-43D894B6-6FA9-4343-A0F2-22D05A96BDB5

Q33244196-7A13E94F-DB10-47C8-960A-2231F2E8982C

Q33244196-7FDEAC9A-DCA0-42A3-B132-EBB16E7AB626

Q33244196-9C1853C9-57A1-4548-879B-5E8F732499F5

Q33244196-D3494BF7-992D-4FBF-8F68-EF7D03640A12

Q33244196-DC0CB6A8-44B4-4FB1-BEA9-CDD2AB26D9A8

Q33244196-E4949A7F-88B6-497F-A260-066683B96E35

P2860

Q33244196-05C295C1-85AE-4657-AE1D-8CB95D285971

Q33244196-15D87017-4C21-4AA0-AC69-11FA3B767CB1

Q33244196-1E860F50-CEAD-4574-A366-566CC5B392BB

Q33244196-31311A5C-24BD-4ED3-87CE-B6113C695FBE

Q33244196-52789212-DFF3-4E93-8EAF-4FA77788E77B

Q33244196-5CFDE561-CDD6-400D-9628-6F4714343BD2

Q33244196-985CB0F4-705F-4BA3-A2EA-5B9268ED53EB

Q33244196-9BC9B85F-841D-43D6-8610-3BCBA6BA8CB8

Q33244196-A2B8674B-F27A-41C3-A616-720326CAF2CF

Q33244196-ABF2DCBC-080B-4CAF-B843-8088F6EC030C

P304

Q33244196-D1DB7354-1CF7-4845-8893-38FDC371608D

P31

Q33244196-6EAED35F-39FE-4EA1-8A03-7BDE5DF29262

P356

Q33244196-F941ABE9-FDE2-43B5-ADA3-5ACD651177D9

P407

Q33244196-87375974-ACB9-435D-B003-AA2C5EDF22ED

P433

Q33244196-FE34CA42-5D72-44C7-BF21-937A0A73E6A3

P478

Q33244196-EDC7DAA7-F59B-42BA-80B2-8801A1EC1011

P50

Q33244196-4DDDAC3B-E635-4506-9025-A0DDDB346445

Q33244196-E2DDFB29-BE10-4FFD-8B5F-B64EF5025D9D

P577

Q33244196-F80122A8-4B05-4DBC-953A-94F94610CEC1

P698

Q33244196-EE48BE16-6A4D-41D0-8E4A-435B4A467366

P921

Q33244196-3333B667-C6AD-42F8-938C-43DF4F9332CF

Q33244196-41C247E5-C55F-40C9-9518-562E6582CD5A

P932

Q33244196-C37F231D-A309-4BEF-8847-4A139EFB42DB

P356

P1433

Infection and Immunity

P1476

Elevated plasma phenylalanine ...... of neurological complications.

@en

P2093

Bert K Lopansri

http://www.w3.org/2001/XMLSchema#string

Craig S Boutlis

http://www.w3.org/2001/XMLSchema#string

Donald L Granger

http://www.w3.org/2001/XMLSchema#string

Esther D Mwaikambo

http://www.w3.org/2001/XMLSchema#string

Gregory J Stoddard

http://www.w3.org/2001/XMLSchema#string

Helena Maniboey

http://www.w3.org/2001/XMLSchema#string

J Brice Weinberg

http://www.w3.org/2001/XMLSchema#string

Marc C Levesque

http://www.w3.org/2001/XMLSchema#string

Maurine R Hobbs

http://www.w3.org/2001/XMLSchema#string

P2860

The significance and mechanism of an increased serum phenylalanine-tyrosine ratio during infection

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster

Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adults

Regulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterin.

Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease).

Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression.

An evaluation of the possible neurotoxicity of metabolites of phenylalanine.

Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria.

A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria.

Direct analysis of tetrahydrobiopterin in cerebrospinal fluid by high-performance liquid chromatography with redox electrochemistry: prevention of autoxidation during storage and analysis.

P304

3355-3359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.02106-05

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas M Anstey

Emiliana Tjitra

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16714564

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

1479261

http://www.w3.org/2001/XMLSchema#string